Biohaven Ltd.
BHVN
$9.20
$0.121.32%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -130.53M | -145.56M | -173.44M | -198.15M | -221.68M |
| Total Depreciation and Amortization | 2.37M | 2.57M | 3.13M | 1.98M | 2.25M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.32M | 22.15M | 27.61M | 9.68M | 58.67M |
| Change in Net Operating Assets | -53.07M | -9.83M | -3.01M | 18.56M | -4.37M |
| Cash from Operations | -149.92M | -130.66M | -145.72M | -167.94M | -165.12M |
| Capital Expenditure | -- | -8.00K | -13.00K | -233.00K | -461.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.21M | -13.73M | 164.98M | -15.31M | 165.34M |
| Cash from Investing | 15.21M | -13.74M | 164.97M | -15.55M | 164.88M |
| Total Debt Issued | -- | 0.00 | 0.00 | 250.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 179.02M | 189.44M | 122.00K | 1.08M | 369.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -644.00K | 0.00 | -1.25M | -- |
| Cash from Financing | 179.02M | 188.80M | 122.00K | 249.83M | 369.00K |
| Foreign Exchange rate Adjustments | 16.00K | 0.00 | 14.00K | -40.00K | 23.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.33M | 44.40M | 19.39M | 66.31M | 147.00K |